Summary of Significant Accounting Policies | Description of Business. Basis of Presentation . The financial statements do not include certain footnote disclosures and financial information normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America and, therefore, should be read in conjunction with the financial statements and notes included in the Company's Annual Report on Form 10-K for the year ended December 31, 2015. The Summary of Significant Accounting Policies in the Companys 2015 Annual Report on Form 10-K describes the Companys accounting policies. Inventories . September 30, December 31, 2016 2015 Raw materials $ 91,000 $ 69,000 Work-in-process 14,000 4,000 Finished goods 470,000 318,000 $ 575,000 $ 391,000 Property and Equipment . September 30, December 31, Property and Equipment: Production tooling, machinery and equipment $ 3,596,000 $ 3,722,000 Office furniture and fixtures 322,000 145,000 Computer equipment and software 1,280,000 1,233,000 Web site 40,000 40,000 Leasehold improvements 577,000 Construction in-progress 220,000 616,000 6,035,000 5,756,000 Accumulated depreciation and amortization (4,505,000 ) (4,172,000 ) Net Property and Equipment $ 1,530,000 $ 1,584,000 Depreciation expense was approximately $187,000 and $577,000 in the three and nine months ended September 30, 2016, respectively, and $160,000 and $482,000 in the three and nine months ended September 30, 2015, respectively. Stock-Based Compensation The Company issued options to purchase an aggregate of 20,000 shares of common stock under its 2013 Omnibus Stock and Incentive Plan, as amended (the 2013 Plan), with a weighted average exercise price of $2.90, during the nine months ended September 30, 2016. The Company estimated the fair value of these awards using the following weighted average assumptions: expected life of 2.5 years, expected volatility of 41%, dividend yield of 0% and risk-free interest rate of 1.00%. The Company issued options to purchase an aggregate of 200,000 shares of common stock under the 2013 Plan, as amended, with a weighted average exercise price of $2.82, during the nine months ended September 30, 2015. The Company estimated the fair value of these awards using the following weighted average assumptions: expected life of 3.4 years, expected volatility of 45%, dividend yield of 0% and risk-free interest rate of 1.18%. During the nine months ended September 30, 2016, the Company issued 100,000 shares of restricted stock under the 2013 Plan. The shares underlying the award were assigned a value of $2.33 per share, which was the closing price of our common stock on the date of grant, and is scheduled to vest over the five years following the date of grant. No restricted stock was issued during the nine months ended September 30, 2015. During the nine months ended September 30, 2016, the Company issued 11,719 performance-based restricted stock units under the 2013 Plan. Each unit represents the right to acquire one share of the Companys common stock. The units were assigned a weighted average value of $0.85 per unit, based on market condition assumptions, and are scheduled to vest with respect to 80% of the units if the price of the Companys common stock during the applicable measurement period exceeds a minimum performance threshold or 100% if a maximum performance threshold is exceeded. No performance-based restricted stock units were issued during the nine months ended September 30, 2015. During the nine months ended September 30, 2016, the Company issued 43,625 restricted stock units under the 2013 Plan. The units were assigned a weighted average value of $2.14 per share, based on the closing price of our common stock on the applicable dates of grant, and are scheduled to vest over the two years. During the nine months ended September 30, 2015, the Company issued 99,000 restricted stock units. The units were assigned a weighted average value of $2.71 per share, based on the closing price of our common stock on the applicable dates of grant, and are scheduled to vest over a weighted average of 2.3 years. Each of the foregoing restricted stock units represents the right to acquire one share of the Companys common stock. The Company estimated the fair value of stock-based awards granted during the nine months ended September 30, 2016, under the Companys employee stock purchase plan using the following weighted average assumptions: expected life of 1.0 years, expected volatility of 31%, dividend yield of 0% and risk-free interest rate of 0.61%. During May and June 2016, members of the Board of Directors received grants totaling 54,036 fully vested shares of common stock pursuant to the 2013 Plan. The shares were assigned a weighted average value of $2.19 per share, based on the stock prices on the applicable grant dates, for a total value of $119,000, of which $109,000 is included in stock-based compensation expense for the nine months ended September 30, 2016 and $10,000 was accrued for and expensed in the prior year. In June 2015, members of the Board of Directors received similar grants totaling 37,233 shares pursuant to the 2013 Plan. The shares were assigned a value of $2.82 per share, based on the stock price on the date of grant, for a total value of $105,000, which is included in stock-based compensation expense for the nine months ended September 30, 2015. Total stock-based compensation (benefit) expense recorded for the three and nine months ended September 30, 2016 was $42,000 and $150,000, respectively, and for the three and nine months ended September 30, 2015 was $(11,000) and $267,000, respectively. During the three and nine months ended September 30, 2016, there were approximately 54,700 shares and 115,700 shares issued pursuant to stock option exercises, for which the Company received proceeds of $0 and $16,000, respectively. During the three and nine months ended September 30, 2015, there were approximately 80,000 shares and 113,000 shares issued pursuant to stock option exercises, for which the Company received proceeds of $0 and $2,000, respectively. A portion of the stock option exercises in the three and nine months ended September 30, 2016 and 2015 were completed on a cashless basis. Net Income (Loss) per Share . Due to the net loss incurred during the three and nine months ended September 30, 2016, all stock awards were anti-dilutive for the period. Options to purchase approximately 660,000 and 653,000 shares of common stock with a weighted average exercise price of $3.64 and $3.80, respectively, were outstanding at September 30, 2015 and were not included in the computation of common stock equivalents for the three and nine months ended September 30, 2015 because their exercise prices were higher than the average fair market value of the common shares during the reporting period. Weighted average common shares outstanding for the three and nine months ended September 30, 2016 and 2015 were as follows: Three Months Ended Nine Months Ended September 30 September 30 2016 2015 2016 2015 Denominator for basic net income (loss) per share - 11,642,000 12,107,000 11,626,000 12,177,000 Effect of dilutive securities: Stock options and restricted stock units and awards 134,000 174,000 Denominator for diluted net income (loss) per share - 11,642,000 12,241,000 11,626,000 12,351,000 |